Kayla Yinger
Women's Health · Corona, CANPI 1366435315
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.8% of the total across 81 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 19 manufacturers reported payments, led by AbbVie at 25.5% of the total.
Across 81 payments — averaging $17.64 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$364
- Mayne Pharma Commercial LLC$134
- Exeltis, USA Inc.$124
- Organon$121
- Pfizer$116
- Myovant Sciences Inc.$92
- plus $478 from 13 others
What the payments were for
- Food & beverage$1,41199%
- Education$171%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 22 | $364 |
| Mayne Pharma Commercial LLC | 14 | $134 |
| Exeltis, USA Inc. | 5 | $124 |
| Organon | 5 | $121 |
| Pfizer | 7 | $116 |
| Myovant Sciences Inc. | 5 | $92 |
| Sumitomo Pharma America, Inc. | 4 | $87 |
| Astellas Pharma US Inc | 2 | $56 |
| Agile Therapeutics, Inc. | 3 | $49 |
| Johnson & Johnson | 2 | $45 |
| Bayer | 2 | $43 |
| Hologic Sales And Service, LLC | 2 | $41 |
| Ascend Therapeutics US, LLC | 2 | $38 |
| Aspira Women's Health Inc | 1 | $36 |
| Coopersurgical, Inc. | 1 | $21 |
| Therapeuticsmd, Inc. | 1 | $17 |
| Scynexis, Inc. | 1 | $17 |
| Avion Pharmaceuticals | 1 | $15 |
| Medicem Inc. | 1 | $13 |
How this compares
$1,429 in reported general payments places this provider in the 85th percentile of 480 women's health providers in California.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| ProgesteroneProgesterone, Micronized | 23 | $958 |
| Medroxyprogesterone Acetate | 22 | $938 |
| Clobetasol Propionate | 31 | $373 |
| Estradiol | 19 | $275 |
| Terconazole | 11 | $245 |
| Levothyroxine Sodium | 11 | $88 |
| Escitalopram Oxalate | 11 | $47 |
Paid to pharmacies, not to this prescriber.
Other women's health in Corona
- Amy GrayCorona$1K
- Barbara DehnMountain View$87K
- Zaruhi HarutyunyanWest Hollywood$55K
- Roberta MoradfarWest Hollywood$30K
- Patricia GeraghtyWalnut Creek$26K
- Katherine KetzStockton$26K
- Debbie BarishBerkeley$16K
- Raisa HowardEl Segundo$11K
- Mary FesselWoodland$8K
- Kay MorelandSanta Maria$6K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.